C H Behrens - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

C H Behrens

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Cancer Chemotherapy and Pharmacology|January 1, 1994

Evaluation of a novel bis-naphthalimide anticancer agent, DMP 840, against human xenografts derived from adult, juvenile, and pediatric cancersP J Houghton, P J Cheshire, J C Hallman, et al.

Cancer Research|April 15, 1994

(R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitroM R Kirshenbaum, S F Chen, C H Behrens, et al.

Anti-Cancer Drugs|August 1, 1993

XB596, a promising bis-naphthalimide anti-cancer agentS F Chen, D L Behrens, C H Behrens, et al.

Investigational New Drugs|December 16, 1998

Preclinical antitumor efficacy of analogs of XK469: sodium-(2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]propionateT H Corbett, P LoRusso, L Demchick, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Cancer Chemotherapy and Pharmacology|January 1, 1994

Evaluation of a novel bis-naphthalimide anticancer agent, DMP 840, against human xenografts derived from adult, juvenile, and pediatric cancersP J Houghton, P J Cheshire, J C Hallman, et al.

Cancer Research|April 15, 1994

(R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitroM R Kirshenbaum, S F Chen, C H Behrens, et al.

Anti-Cancer Drugs|August 1, 1993

XB596, a promising bis-naphthalimide anti-cancer agentS F Chen, D L Behrens, C H Behrens, et al.

Investigational New Drugs|December 16, 1998

Preclinical antitumor efficacy of analogs of XK469: sodium-(2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]propionateT H Corbett, P LoRusso, L Demchick, et al.

Pageof 1